Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (21-30 of 255) with videos related to

Pageof 26
Sort By:
Clinical Genitourinary Cancer|January 21, 2018
Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective StudiesPooja Ghatalia, Gregory R Pond, Arnoud J Templeton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 17, 2024
Nivolumab in Squamous Cell Carcinomas of the Head and Neck (SCCHN): A Real-world Outcome Study in Ontario, CanadaArman Zereshkian, Ruaa Shafi, Gregory R Pond, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma and Associated Risk Factors: A Retrospective Chart ReviewDuaa Binjabal, Nasser Al Majarafi, Gregory R Pond, et al.
Journal of Geriatric Oncology|October 16, 2018
The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, CanadaJordan Doherty, David E Dawe, Gregory R Pond, et al.
Palliative Medicine|August 17, 2011
Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysisPaul Cameron, Peter M Ellis, Gregory R Pond, et al.
Palliative Medicine|June 20, 2013
Are family physician visits and continuity of care associated with acute care use at end-of-life? A population-based cohort study of homecare cancer patientsUmmukulthum Almaawiy, Gregory R Pond, Jonathan Sussman, et al.
Clinical Trials (London, England)|June 21, 2013
Data collection in cancer clinical trials: Too much of a good thing?Erin O'Leary, Hsien Seow, Jim Julian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agentsMark Agulnik, Amit M Oza, Gregory R Pond, et al.
The Journal of Urology|November 21, 2002
"PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancerAisha Lofters, Helen G Juffs, Gregory R Pond, et al.
Journal of Robotic Surgery|November 5, 2015
Independent predictors of prolonged operative time during robotic-assisted radical prostatectomyPhilippe D Violette, David Mikhail, Gregory R Pond, et al.
Pageof 26

Showing results (21-30 of 255) with videos related to

Sort By:
Pageof 26
Clinical Genitourinary Cancer|January 21, 2018
Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective StudiesPooja Ghatalia, Gregory R Pond, Arnoud J Templeton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 17, 2024
Nivolumab in Squamous Cell Carcinomas of the Head and Neck (SCCHN): A Real-world Outcome Study in Ontario, CanadaArman Zereshkian, Ruaa Shafi, Gregory R Pond, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma and Associated Risk Factors: A Retrospective Chart ReviewDuaa Binjabal, Nasser Al Majarafi, Gregory R Pond, et al.
Journal of Geriatric Oncology|October 16, 2018
The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, CanadaJordan Doherty, David E Dawe, Gregory R Pond, et al.
Palliative Medicine|August 17, 2011
Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysisPaul Cameron, Peter M Ellis, Gregory R Pond, et al.
Palliative Medicine|June 20, 2013
Are family physician visits and continuity of care associated with acute care use at end-of-life? A population-based cohort study of homecare cancer patientsUmmukulthum Almaawiy, Gregory R Pond, Jonathan Sussman, et al.
Clinical Trials (London, England)|June 21, 2013
Data collection in cancer clinical trials: Too much of a good thing?Erin O'Leary, Hsien Seow, Jim Julian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agentsMark Agulnik, Amit M Oza, Gregory R Pond, et al.
The Journal of Urology|November 21, 2002
"PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancerAisha Lofters, Helen G Juffs, Gregory R Pond, et al.
Journal of Robotic Surgery|November 5, 2015
Independent predictors of prolonged operative time during robotic-assisted radical prostatectomyPhilippe D Violette, David Mikhail, Gregory R Pond, et al.
Pageof 26